These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3658945)

  • 1. [Lipid composition of thrombocytes in diabetes mellitus depending on the degree of microangiopathy].
    Kasimova GM; Mirtalipov DT; Abidov AA; Akbarov VZ
    Probl Endokrinol (Mosk); 1987; 33(4):20-3. PubMed ID: 3658945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of the system of hemostasis in the development of vascular lesions in diabetes mellitus].
    Lapotnikov VA; Moiseev SI
    Ter Arkh; 1988; 60(9):31-5. PubMed ID: 3217876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheological changes in diabetic microangiopathy.
    Negrean V; Suciu I; Sâmpelean D; Cozma A
    Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet aggregation, platelet cAMP levels and thromboxane B2 synthesis in patients with diabetes mellitus.
    Chen SY; Yu BJ; Liang YQ; Lin WD
    Chin Med J (Engl); 1990 Apr; 103(4):312-8. PubMed ID: 2167823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indobufen induced modification of phospholipid composition in diabetic platelets.
    Dmoszyńska A; Sokołowska B; Walter-Croneck A; Przesmycki K; Ledwozyw A
    Pol J Pharmacol; 1996; 48(3):331-4. PubMed ID: 9112672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between serum lipids, platelet membrane fatty acid composition and platelet aggregation in type 2 diabetes mellitus.
    Rodier M; Colette C; Crastes de Paulet P; Crastes de Paulet A; Monnier L
    Diabete Metab; 1993; 19(6):560-5. PubMed ID: 8026607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane fluidity, membrane lipid pattern, and cytosolic Ca2+ content in platelets from a group of type II diabetic patients with macrovascular complications.
    Caimi G; Lo Presti R; Montana M; Canino B; Ventimiglia G; Romano A; Catania A; Sarno A
    Diabetes Care; 1995 Jan; 18(1):60-3. PubMed ID: 7698049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The atherogenesis characteristics of diabetic patients].
    Prystupiuk OM
    Lik Sprava; 1999; (1):57-9. PubMed ID: 10423999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet adhesiveness in diabetes mellitus with and without vascular complications.
    Ramani A; Kumar S; Tyagi N
    J Assoc Physicians India; 1986 Nov; 34(11):792-3. PubMed ID: 3558304
    [No Abstract]   [Full Text] [Related]  

  • 10. [Morphofunctional changes in the erythrocytes in diabetes mellitus].
    Efimov AS; Pleshanov EV; Gogina IF
    Probl Endokrinol (Mosk); 1988; 34(2):13-5. PubMed ID: 3393498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease.
    Koga H; Sugiyama S; Kugiyama K; Fukushima H; Watanabe K; Sakamoto T; Yoshimura M; Jinnouchi H; Ogawa H
    Eur Heart J; 2006 Apr; 27(7):817-23. PubMed ID: 16434416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The relationship between concentration of growth hormone in serum and microangiopathy in patients with diabetes mellitus].
    Chen M; Yu W; Hu S
    Zhonghua Yi Xue Za Zhi; 1997 Oct; 77(10):765-7. PubMed ID: 9772523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered membrane fatty acid composition and increased thromboxane A2 generation in platelets from patients with diabetes.
    Prisco D; Rogasi PG; Paniccia R; Abbate R; Gensini GF; Pinto S; Vanni D; Neri Serneri GG
    Prostaglandins Leukot Essent Fatty Acids; 1989 Jan; 35(1):15-23. PubMed ID: 2928370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Erythrocyte lipids in diabetes mellitus with vascular involvement].
    Kasimova GM; Mirtalipov DT; Abidov AA; Akbarov ZS
    Vopr Med Khim; 1989; 35(3):42-7. PubMed ID: 2773383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemostasis and lipid metabolism in patients with non-insulin- dependent diabetes mellitus and angiopathy of the lower extremities].
    Mamedgasanov RM; Semavin IE; Smirnova LM; Rudenko GR; Riazanov IuI
    Klin Med (Mosk); 1989 Aug; 67(8):74-6. PubMed ID: 2811244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma, erythrocyte and platelet magnesium in essential hyperTension, diabetes mellitus without and with macrovascular complications and atherosclerotic vascular disease].
    Grifò G; Lo Presti R; Montana M; Canino B; Caimi G
    Recenti Prog Med; 1995 Nov; 86(11):431-6. PubMed ID: 8539474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Disorders of lipid metabolism in diabetes mellitus].
    Biesenbach G
    Wien Med Wochenschr Suppl; 1989; 105():9-17. PubMed ID: 2694631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid compositions of serum lipids, erythrocytes, and platelets in insulin-dependent diabetic women.
    Tilvis RS; Miettinen TA
    J Clin Endocrinol Metab; 1985 Oct; 61(4):741-5. PubMed ID: 4031016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Content of vasopressin and beta2-microglobulin in the blood in patients with diabetes mellitus type II accompanied by microangiopathy].
    Livshits IB; Kostiuk KL; Sherstiuk GB
    Probl Endokrinol (Mosk); 1989; 35(1):15-8. PubMed ID: 2654919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The content of stable forms of prostacyclin I2 and thromboxane A2 in the blood plasma in diabetic angiopathies].
    Sergienko AA
    Probl Endokrinol (Mosk); 1991; 37(4):24-6. PubMed ID: 1788186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.